Results 161 to 170 of about 5,574,124 (309)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Addressing Critical Mistakes in Administering Intravenous Medications at Omdurman Military Hospital, Khartoum, Sudan

International Journal of General Medicine
Waled AM Ahmed,1,2 Amna Eltom Hajo Elsheikh Abdelrahman,3 Amal Abdelgadir Mohamed,4 Ibrahim Osman Mohammed,5 Amna Mohammed Ali Mustafa,6 Zeinab Eltayeb Elfaki Ahmed,7 Maab Mutaz Tagelsir Mohamed,8 Fahad Abdullah A Alghamdi,9 Amira EE Elbashir,10 Sameer ...
Ahmed WAM, Abdelrahman AEHE, Mohamed AA, Mohammed IO, Mustafa AMA, Ahmed ZEE, Mohamed MMT, Alghamdi FAA, Elbashir AEE, Alkubati S, Al-Sowaidi A, Dinar NMAA, Obadi AA, Saleh KA   +13 more
doaj  

Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation. [PDF]

Blood Adv
Nguyen TP, Jiang YG, Ogan BM, Doyle AD, Tran DT, Ward JM, Zhang A, Ferrer de Oliveira R, Ferraresso F, Bledsoe JR, Kastrup CJ, Flick MJ, Rowe RG, Bugge TH, Silva LM.   +14 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

LC-MS/MS Determination of Crotonoside in Rat Plasma and Application to Pharmacokinetic Study. [PDF]

Biomed Chromatogr
Zhang H, Rong D, Qi Q, Liu R, Wang X, Zhang B, Xu W, Yu M, Sy SKB, Wu X.   +9 more
europepmc   +1 more source

Anaesthetics, and their Administration [PDF]

BMJ, 1884
openaire   +2 more sources

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Peripheral administration of 11.7% hypertonic saline and phlebitis risk in acute ischemic stroke requiring hyperosmolar therapy in South Korea. [PDF]

Acute Crit Care
Seo BS, Hong H, Hong JH, Jung J, Kim H.
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Safety of Nonsteroidal Anti-Inflammatory Drug Use in Traumatic Brain Injury. [PDF]

Pharmacotherapy
Beavers J, Shultz MKC, Atchison L, Lwin C, Liu D, Chotai S, Medvecz AJ, Beyene R, Smith MC, Dennis BM, Hamblin S.   +10 more
europepmc   +1 more source